Filing Details
- Accession Number:
- 0001522767-24-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 17:05:01
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 17:05:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1522767 | Marimed Inc. | MRMD | Medicinal Chemicals & Botanical Products (2833) | 274672745 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1789645 | R Jon Levine | C/O Marimed Inc. 10 Oceana Way Norwood, MA 02062 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-07 | 46,667 | $0.00 | 20,245,549 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-07 | 16,529 | $0.23 | 20,229,020 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $.001 Per Share | Restricted Stock Units (RSU) | Disposition | 2024-03-07 | 46,667 | $0.00 | 46,667 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
93,333 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,684,640 | Indirect | By the Jon Levine Family Trust |
Footnotes
- RSUs convert to shares of common stock on a one-for-one basis.
- Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person on March 10, 2023 to satisfy tax withholding obligations in connection with the vesting of RSUs.
- These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- The RSUs vest over a three year period of which 46,667 RSUs vested on March 7, 2024 and thereafter, 23,333 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.